Pharmacovigilance – News and Features

Researchers have developed a nanotechnology-driven solution to locally enhance T-cell functions without producing unwanted systemic side effects.

A study suggests that an unwillingness to accept a COVID-19 vaccine can be due to both a lack of concern for the consequences of contracting the virus and a lack of faith in the government’s actions.

Engineers create a device that enables intestinal organoids to develop to unprecedented levels of maturity.

A new study has challenged the idea that higher amounts of amyloid in the brain is an underlying cause of Alzheimer's disease, instead indicating fibrillary amyloid may be a better indicator of brain health.

Using an approach that simultaneously modifies multiple sites in fungal genomes, scientists coax fungi into revealing their best-kept secrets, ramping up the pace of new drug discovery.

Polystyrene-derived nanoplastics have been found to facilitate the formation of manganese oxide, which can affect the fate and transport of organic contaminants in natural and engineering water systems.

New evidence suggests that a 50-year-old blood pressure drug could find a new purpose as a treatment to mitigate the often life-altering effects of PTSD.

A comprehensive study detailing variations in drug responses across different subtypes of childhood acute lymphoblastic leukemia could provide a blueprint to further individualize therapy.

A three-dose malaria vaccine has demonstrated safety and efficacy when tested in adults in West Africa.

Researchers have explored a new way of administering medications that do not require injections, and instead could be as easy as swallowing a pill.